Effects of acute and repeated treatment with a novel dopamine D 2 receptor ligand on l-DOPA-induced dyskinesias in MPTP monkeys

Author： Tahar A.H.   Ekesbo A.   Gregoire L.   Bangassoro E.   Svensson K.A.   Tedroff J.   Bedard P.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.412, Iss.3, 2001-02, pp. : 247-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias

By  

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 481-493

Bentham Science Publishers

Access to resources Recommend Favorite

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio   Armentero Marie-Therese  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

Effects of asimilobine on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells

By Jin Chun-Mei  

Journal of Asian Natural Products Research, Vol. 10, Iss. 8, 2008-08 ,pp. : 737-745

Taylor & Francis Ltd

Access to resources Recommend Favorite

Receptor Heteromers in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1101-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D 1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958

By Grondin R.   Goulet M.   Morissette M.   Bedard P.J.   Di Paolo T.  

European Journal of Pharmacology, Vol. 378, Iss. 3, 1999-08 ,pp. : 259-263

Elsevier

Access to resources Recommend Favorite